107 related articles for article (PubMed ID: 8496942)
21. Substrate specificity of squalene synthetase.
Koyama T; Ogura K; Seto S
Biochim Biophys Acta; 1980 Feb; 617(2):218-24. PubMed ID: 7357018
[TBL] [Abstract][Full Text] [Related]
22. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
[TBL] [Abstract][Full Text] [Related]
23. CJ-13,981 and CJ-13,982, new squalene synthase inhibitors.
Watanabe S; Hirai H; Kambara T; Kojima Y; Nishida H; Sugiura A; Yamauchi Y; Yoshikawa N; Harwood HJ; Huang LH; Kojima N
J Antibiot (Tokyo); 2001 Dec; 54(12):1025-30. PubMed ID: 11858656
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of squalene biosynthesis and metabolism.
Abe I; Tomesch JC; Wattanasin S; Prestwich GD
Nat Prod Rep; 1994 Jun; 11(3):279-302. PubMed ID: 15200015
[No Abstract] [Full Text] [Related]
25. 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate.
Magnin DR; Biller SA; Dickson JK; Logan JV; Lawrence RM; Chen Y; Sulsky RB; Ciosek CP; Harrity TW; Jolibois KG
J Med Chem; 1995 Jul; 38(14):2596-605. PubMed ID: 7629799
[TBL] [Abstract][Full Text] [Related]
26. Regulation of squalene synthetase activity in rat liver: elevation by cholestyramine, but no diurnal variation.
Cohen LH; Griffioen AM; Wanders RJ; Van Roermund CW; Huysmans CM; Princen HM
Biochem Biophys Res Commun; 1986 Jul; 138(1):335-41. PubMed ID: 2943275
[TBL] [Abstract][Full Text] [Related]
27. Substrate selectivity of squalene synthetase.
Ortiz de Montellano PR; Wei JS; Vinson WA; Castillo R; Boparai AS
Biochemistry; 1977 Jun; 16(12):2680-5. PubMed ID: 329862
[TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of the water-soluble squalene synthase from Methylococcus capsulatus and the functional analyses of its two DXXD(E)D motifs and the highly conserved aromatic amino acid residues.
Ohtake K; Saito N; Shibuya S; Kobayashi W; Amano R; Hirai T; Sasaki S; Nakano C; Hoshino T
FEBS J; 2014 Dec; 281(24):5479-97. PubMed ID: 25283713
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of inhibition of yeast squalene synthase by substrate analog inhibitors.
Kalinowski SS; Mookhtiar KA
Arch Biochem Biophys; 1999 Aug; 368(2):338-46. PubMed ID: 10441385
[TBL] [Abstract][Full Text] [Related]
30. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
[TBL] [Abstract][Full Text] [Related]
31. Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes.
Bansal VS; Vaidya S
Arch Biochem Biophys; 1994 Dec; 315(2):393-9. PubMed ID: 7986083
[TBL] [Abstract][Full Text] [Related]
32. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action and inhibition of dehydrosqualene synthase.
Lin FY; Liu CI; Liu YL; Zhang Y; Wang K; Jeng WY; Ko TP; Cao R; Wang AH; Oldfield E
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21337-42. PubMed ID: 21098670
[TBL] [Abstract][Full Text] [Related]
34. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities.
Kuswik-Rabiega G; Rilling HC
J Biol Chem; 1987 Feb; 262(4):1505-9. PubMed ID: 3805037
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of prenyl alcohols by terpenoid biosynthesis inhibitors in various microorganisms.
Muramatsu M; Ohto C; Obata S; Sakuradani E; Shimizu S
Appl Microbiol Biotechnol; 2008 Sep; 80(4):589-95. PubMed ID: 18636253
[TBL] [Abstract][Full Text] [Related]
36. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
37. Squalene synthetase.
Agnew WS
Methods Enzymol; 1985; 110():359-73. PubMed ID: 3894879
[No Abstract] [Full Text] [Related]
38. Polyisoprenoid amphiphilic compounds as inhibitors of squalene synthesis and other microsomal enzymes.
Bertolino A; Altman LJ; Vasak J; Rilling HC
Biochim Biophys Acta; 1978 Jul; 530(1):17-23. PubMed ID: 210830
[TBL] [Abstract][Full Text] [Related]
39. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.
Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE
J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.
McTaggart F; Brown GR; Davidson RG; Freeman S; Holdgate GA; Mallion KB; Mirrlees DJ; Smith GJ; Ward WH
Biochem Pharmacol; 1996 Jun; 51(11):1477-87. PubMed ID: 8630089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
